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Summary Cleft lip with or without cleft palate is the most common congenital anomaly in
craniofacial complex, which is our target to deepen our understanding toward amolecular mechan-
ismofdento-craniofacialmorphogenesis. Thehypothesis that thematernal effects in addition to the
genetic ones play important roles on the dento-craniofacial morphogenesis in mice has been tested
based on each developmental stage. Firstly, the maternal effects on the intrauterine craniofacial
development in the mouse fetus were examined by means of embryo transfer technique, skeletal
stainingandcephalometry, indicating that thematernaleffectswereoneof important factors on the
intrauterine craniofacial morphogenesis of CL/Fr mice. Secondly, when themolecular nature of the
maternaleffects iselucidated,maternallyderivedgrowth factorsmayplay important rolesonmouse
fetus development. Bone morphogenetic protein 4 (BMP4) and epidermal growth factor (EGF)
function antagonistically, yet are coupled in the regulation of initial chondrogenesis. Smad1 serves
asapointofconvergence for the integrationof twodifferentgrowth factor signalingpathwaysduring
chondrogenesis in the mouse fetal mandible. Lastly, transforming growth factor-beta3 (TGF-b3)
promotedfusionofcleft lip in themousefetusthroughthemolecularpathways. Infact,microsurgical
repair of cleft lip in the fetus that produced scarless fusion is mediated by TGF-b3 regulation of
mesenchymal cell proliferation andmigration at the siteof repair. In addition, TGF-b3promotedcell
proliferation and angiogenesis in lipmesenchymal tissues. These events lead to enhancement of the
lip fusion inthepresenceofTGF-b3. Inneonatalmouse,applicationofexogenousTGF-b3todecrease
type I collagen accumulation and consequential scar formation provide the opportunities for the
clinical augmentation of scar reduction after cleft lip repair. These findings indicate that the
environmental factors provided by the dams cannot be ignored in the etiology of a craniofacial
anomaly and/or development in the mouse model in addition to genetic ones.
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128 K. NonakaIn mammalian, craniofacial development of the offsprings is
influenced by its own genotype, maternal effects and non-
maternal environmental factors. The maternal effects are
composed of the prenatal and postnatal effects from dams.
The prenatal effects are mainly due to the intrauterine
condition of dams while the postnatal ones are mainly due
to the breast feeding ability and nursing of dams (Fig. 1). In
the mouse model, the prenatal effects of dams on the
intrauterine dento-craniofacial development in the mouse
fetus were examined by means of the embryo transfer
technique [1], while genetic effects on dento-craniofacial
development were studied using twin mice production [2].
Furthermore, the postnatal maternal effects on offspring
development can be distinguished from the prenatal mater-
nal ones by a cross-nursing method of dams. For example, a
mutual exchange of a half of the litters between two strains
of dams enables us to examine the inter-nursing difference
of the postnatal development of the same genotype
offspring derived from either the self-nursing or the cross-
nursing dam [3].
Dento-craniofacial morphogenesis is greatly dependant on
migration, proliferation and differentiation of cranial neural
crest cells [4,5]. Cross talking between cell-to-cell and cell-
to-extra-cellular matrix including basement membrane are
always involved through craniofacial morphogenesis.
Furthermore, complicated interactions continuously occur
at the levels of the ligands, receptors, cytoplasmic transdu-
cers, transcription and translation processes followed by
post-translational processes involving protein glycosylation,
phosphorylation, and proteolysis. Cleft lip and palate (CLP) is
one of major neurocriptopathies caused by abnormal migra-
tion, proliferation or differentiation of cranial neural crest
cells and the occurrence rate of CLP is 1:700 in Orientals. CL/
Fr mice strain, which has almost 25—35% spontaneous occur-
rence rate of CLP, gives us the good opportunities to examine
the genetic, maternal and non-maternal environmental
effects from the fetal to neonatal stages on CLP onset
[6,7]. Epidermal growth factor (EGF) is considered to be
predominately supplied to fetuses or newborns from the
mothers through their placenta, amniotic fluid or breast
feeding because of its poor gene expression level in the mice
fetal tissues. Therefore, many maternally derived growth
factors might play important roles in dento-craniofacial
morphogenesis through cartilage formation in the mouse
fetus [8]. However, detailed molecular mechanisms of theFigure 1 Development of offspring in mammalian.dento-craniofacial morphogenesis or development by the
maternal effects at the prenatal and postnatal stages are
still unknown. The purpose in this review is to focus on
molecular dissection of the maternal influences on the CLP
occurrence and the dento-craniofacial development from the
fetal stage to young adulthood. Serial challenges including
experimental techniques in embryology as well as molecular
biology have been introduced at each developmental stage.
These challenges could contribute to the molecular dissec-
tion of maternal effects during the fetal period in addition to
genetic ones on the dento-craniofacial development of the
fetus and newborn, and to providing the opportunities for
exploring the prevention and molecular therapy against
human craniofacial anomaly in future.
1. The effects of dams on the craniofacial
morphogenesis in CL/Fr mice fetuses
Well-developed CL/Fr blastocysts are surgically transferred
into the pseudo-pregnant uteri of two kinds of the recipient
mice strain, CL/Fr and C57BL females, by the microcapillary
technique [9]. The dams were taken out from each recipient
by laparatomy on the 18th gestational day to investigate the
spontaneous incidence of CLP and the craniofacial structure
change. The following results were obtained: (1) The CLP
frequency was significantly higher in dams derived from CL/
Fr recipient than C57BL. (2) The conditions of CL/Fr recipi-
ent-derived fetuses with CLP were significantly more serious
than C57BL recipient-derived ones. (3) The overall craniofa-
cial sizes of the unaffected fetuses from CL/Fr recipient were
significantly smaller than those from C57BL recipient. Those
of the affected dams from CL/Fr recipient were smaller than
those from C57BL recipient although the inter-strain differ-
ence was not significant. (4) The dam strains had highly
significant effects on the craniofacial size of the unaffected
fetuses. These results suggested that prenatal effects from
the dams played important roles on the incidence of CLP in
CL/Fr mice fetuses.
2. Convergence of the BMP and EGF signaling
pathways on Smad1 in the regulation of
chondrogenesis
It is hypothesized that bone morphogenetic protein 4 (BMP4)
and EGFmediated intracellular signals are both coupled in the
regulation of Meckel’s cartilage development. To investigate
the reciprocal effects of BMP4 and EGF during chondrogenesis,
the organ culture systemof themousemandibular process and
micromass culture system for chicken embryonic mandibular
process were performed [10]. When BMP4- and EGF-soaked
beads were implanted in juxtapositions of mouse mandible
processes within embryonic day 10, the incidence and amount
of ectopic cartilage, and Sox9 and type II collagen expression
were significantly reduced and increased by BMP4 and EGF,
respectively, in a dose-dependent manner. Similarly, in
chicken serum-free micromass cultures, expression of consti-
tutively active BMP receptor type IB by replication competent
avian retrovirus system promoted the rate and extent of
chondrogenesis; however, exogenous EGF attenuated these
effects. In micromass cultures, BMP signaling resulted
in nuclear translocation and accumulation of the signaling
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events. Two culture systems demonstrated that BMP4 induces,
whereas EGF inhibits chondrogenesis. These results suggested
the possibility that exogenous EGF might mimic a maternally
derived growth factor which inhibited important roles on
chondrogenesis induced by BMP through Smad1 signaling.
3. Promotion of scarless repair and
angiogenesis in cleft lip of mouse fetuses by
TGF-b3
Fetal surgery for repairing the cleft lip was performed on the
anesthetized CL/Fr pregnant female mice under microscopy
[11]. The fetus with a bilateral cleft upper lip was identified
through the uterine wall, and exposed for fetal surgery. The
left cleft was sutured (operated group), while the contral-
ateral side was allowed to develop without repairing as the
control group. It was demonstrated that the fetuses with the
cleft lips were repaired by fetal surgery, producing scarless
fusion. At the site of the operation, we first observed an
infusion of platelets expressing transforming growth factor-
beta3 (TGF-b3), followed by increased expression of Cyclin
D1 and tenascin-C, and coupled with increased mesenchymal
cell proliferation. In ex vivo serum-free culture system, cleft
lip explants fused in the presence of exogenous TGF-b3.
Cultured lips also showed upregulations of Cyclin D1 and
tenascin-C expression. These findings suggest that microsur-
gical repair of cleft lip in the fetus that produced scarless
fusion is mediated by TGF-b3 regulation of mesenchymal cell
proliferation and migration at the site of repair [11].
During normal development, we detected positive immu-
noreactions for TGF-b3 at the site of fusion. We also detected
mesenchymal cells immunopositive for Flk-1 and CD31, mar-
kers for endothelial cell precursors. In addition, embryonic
lips isolated from 11.5-day-old CL/Fr mouse embryos were
allowed to develop in serum-free organ cultures in the pre-
sence or absence of TGF-b3 [12]. Lips developed fused in 2
days normally and exogenous TGF-b3 accelerated lip fusion
in these cultures. This enhancement was associated with an
increase in the number of capillary blood vessels in the lip
cultured in the presence of TGF-b3 compared with in the
absent of TGF-b3. In tandem, TGF-b3 increased the expres-
sion levels of both Flk-1 and CD31. Our data suggest that the
elevation of TGF-b3 could promote angiogenesis in develop-
ing lips, and mediated by increased Flk-1 and CD31 expres-
sion. In the presence of TGF-b3, we also detected
upregulation of Cyclin D1 expression, suggesting that TGF-
b3 promoted cell proliferation [12].
4. Reduction of scar formation after
labioplasty by TGF-b3
Surgical repair of cleft lip in newborns may result in signifi-
cant scar formation due to excessive tension and contraction.
However, repair of cleft lip in animal fetuses in utero appears
to produce relatively scarless results [13]. The developmen-
tal basis, and cellular and molecular mechanisms for scarless
repair of cleft lip in utero is unclear, although secreted
growth factors have been implicated for use in augmenting
repair [14]. We hypothesized that TGF-b3 has importantfunctions on the scarless repair of cleft lip [15]. It was
demonstrated that exogenous TGF-b3 reduced scar forma-
tion in an incised and sutured mouse lip in vivo. During
labioplasty, endogenous TGF-b3 expression was also ele-
vated. In vitro experiments showed that exogenous TGF-
b3 reduced type I collagen accumulation in the cells isolated
from the lip of neonatal CL/Fr mice. Furthermore, TGF-b3
inhibited alpha-smooth-muscle actin expression, a marker
for myofibroblasts. In tandem, TGF-b3 induced the expres-
sion and activity of MMP-9. Analysis of our data suggests that
TGF-b3 is normally secreted following labioplastic wound
healing. An elevated level of TGF-b3 reduces type I collagen
deposition by restricting myofibroblast differentiation and
thereby collagen synthesis, and by promoting collagen degra-
dation by MMP-9. In combination with above results, it was
indicated that TGF-b3 could mediate reduction of the scar
formation during labioplasty.
5. Discussion
The results obtained from surgically fertilized embryo trans-
fer to examine prenatal maternal influences on CLP indicated
that the CLP-susceptible CL/Fr dam strain retarded the
intrauterine craniofacial development of the fetuses and
the cleft condition in the affected fetuses observed in the
CL/Fr dam strain was more serious than that seen in the CLP-
resistant C57BL dam strain [9]. Thus, it could be suggested
that the effects of the dam strains played important roles in
the craniofacial morphogenesis of the CL/Fr fetuses devel-
oped from CL/Fr and C57BL dam strains along with the
genotype of the embryos. A delayed chronologic craniofacial
development in the CLP-susceptible CL/Fr mice strain was
observed in comparison with that in the CLP-resistant C57BL
mice strain. The morphogenetic and the anatomical features
observed in the CL/Fr fetuses could be related with the
failures of the facial processes fusions and thus the sponta-
neous incidence of CLP. A differential volume of nutrient,
oxygenation of the maternal blood, or blood supply to the
fetus through the uterine arteries and placenta in the dam
might retard fetal development. The maternal endocrine
function also could affect the incidence of CLP. Some harmful
agents such as cortisone induced through the placenta of a
dam could be one of the factors responsible for the etiology
of the CLP induction. The uterine environment provided by
the CL/Fr dam strain contributed toward enhancing the
severity of CLP in the fetus, although further investigations
were required for the elucidation of the exact mechanisms.
While EGF can act as a potent growth factor for the
regulation of the offspring development, its gene expression
is poor in the fetus. Therefore, EGF is predominately supplied
to the fetus and baby from the mother through the placenta,
amniotic fluid, breast feeding and saliva. It was shown that
sialoadenectomy of a submaxillary gland in a pregnant
female mouse decreased her mammary gland growth and
then her lowered milk production caused the increasing of
the offspring mortality rate. By contrast, EGF administration
to the sialoadenectomized pregnant female was able to
enhance the offspring survival rate at almost same level of
the offspring nursed by the normal dam. However, the bio-
logical effects of maternally derived EGF on dento-cranio-
facial development of the fetus or newborn are not well
130 K. Nonakaunderstood. Although it is unclear how mechanistically the
TGF-b isoforms produce different outcomes during wound
healing and how specifically TGF-b3 reduces scar formation,
the use of this CL/Fr mice strain as an experimental model
coupled with surgery and repair enabled us to study the
molecular events and mechanisms of the developmental
process of lip fusion and scarless repair of cleft lip in the
neonatal mice.
We discovered that TGF-b3 might promote two cellular
events at the site of the fetal surgery [10]. We firstly detected
theupregulation ofCyclinD1 transcripts in tissues at the site of
the repairing cleft lip. Inmesenchymal cell culture, exogenous
TGF-b3 results in the upregulation of Cyclin D1 expression,
thus further supporting the hypothesis that TGF-b3 can
enhance cell proliferation and induce Cyclin D1 expression.
In addition to enhancing cell proliferation, the increase in the
total number of mesenchymal cells which contributed to lip
fusion could also be the result of promoting cell migration into
the repairing sites. Tenascin functions in modifying the adhe-
sive properties of the extracellular matrix and allows for
increasing cell motility. Secondly, we detected increasing
the accumulation of tenascin at the repairing sites, which
was also supportedbyourobservation that tenascin expression
was upregulated in the presence of TGF-b3 in mesenchymal
cell culture. We speculate that tenascin could facilitate the
migration ofmesenchymal cells into the repairing sites, thus in
part accounting for the increase in total mesenchymal cell
number and contributing toward lip fusion. These findings
obtained from the surgery experiments of CLP in CL/Fr fetus
suggested that microsurgical repair of cleft lip that produced
the scarless fusion was mediated by TGF-b3 which regulated
the proliferation and migration of the mesenchymal cells at
and into the reparing sites, respectively.
Children, who visit pedodontists, are in the process of
growing from a newborn baby up to a teen-ager. Thus, to
deepen our understanding of the molecular mechanisms of
dento-craniofacial developmentmight help us to improve our
clinical strategy. The accumulated knowledge about the
molecular mechanisms of prominence fusion during cranio-
facial morphogenesis will be able to contribute to better
intervention and improved functional outcome in clinical
pediatric dentistry.
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